Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia

References

• Bennett RM, Cook DM, Clark SR, Burckhardt CS, Campbell SM. Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. J Rheumatol 1997;24:1384–9.
   Google Scholar
• Russell IJ, On MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593–601.
   PubMed Web of Science ®Google Scholar
• Russell U. Advances in fibromyalgia: possible role for central neurochemicals. Am J Med Sci 1998;315:377–84.
   PubMed Web of Science ®Google Scholar
• Vaeroy H, Helle R, Forre 0, Kass E, Terenius L. Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 1988; 15:1804–6.
   Google Scholar
• Neeck G, Crofford U. Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am 2000;26:989–1002.
   PubMed Web of Science ®Google Scholar
• Mense S. Neurobiological concepts of fibromyalgia - the possible role of descending spinal tracts. Scand J Rheumatol 2000;29 Suppl 113:24–9.
   Google Scholar
• Yunus MB, Khan MA, Rawlings KK, Green JR, Olson JM, Shah S. Genetic linkage analysis of multicase families with fibromyalgia syndrome. J Rheumatol 1999;26:408–12.
   PubMed Web of Science ®Google Scholar
• Haus U, Varga B, Stratz T, Späth M, Milller W. Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psycho-metric parameters and pain. Scand J Rheumatol 2000;29 Suppl 113:55–8.
   Google Scholar
• Farber L, Stratz T, Bruckle W, Spath M, Pongratz D, Lautenschlager J, et al. Efficacy and tolerability of tropisetron in primary fibromyalgia - a highly selective and competitive 5-HT3 receptor antagonist. Scand J Rheumatol 2000; 29 Suppl 113:49–54.
   Google Scholar
• Papadopoulos IA, Georgiou PE, Katsimbri PP, Drosos AA. Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study. Clin Rheumatol 2000;19:6–8.
   PubMed Web of Science ®Google Scholar
• Spath M. Current experience with 5-HT3 receptor antagonists in fibromyalgia. Rheum Dis Clin North Am 2002;28:319–28.
   PubMed Web of Science ®Google Scholar
• Stratz T, Schochat T, Hrycaj P, Lacki J, Mennet P, Faber L, et al. [Therapy of generali7ed tendomyopathy (fibromyalgia) caused by blocking 5-HT3 receptors]. Z Rheumatol 1994; 53:335–8.
   PubMed Web of Science ®Google Scholar
• Stratz T, Farber L, Varga B, Baumgartner C, Haus U, Muller W. Fibromyalgia treatment with intravenous tropisetron admin-istration. Drugs Exp Clin Res 2001;27:113–8.
   PubMedGoogle Scholar
• Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–71.
   PubMed Web of Science ®Google Scholar
• Hautzinger M. [The Beck Depression Inventory in clinical practice]. Nervenarzt 1991;62:689–96.
   PubMed Web of Science ®Google Scholar
• Likert R. Rensis Likert on managing human assets. Bull Train 1978;3:1–4.
   PubMedGoogle Scholar
• Muller W. [Generalized tendomyopathy (fibromyalgia)]. Z Gesamte Inn Med 1991;46:361–9.
   PubMedGoogle Scholar
• Miiller W, Lautenschlager J. [Generalized tendomyopathy (GTM) - Part 1: Clinics, course and differential diagnosis]. Z Rheumatol 1990;49:11–21.
   PubMed Web of Science ®Google Scholar
• Hewett JE, Buckelew SP, Johnson JC, Shaw SE, Huyser B, Fu YZ. Selection of measures suitable for evaluating change in fibromyalgia clinical trials. J Rheumatol 1995;22:2307–12.
   PubMed Web of Science ®Google Scholar
• Jacobs JW, Geenen R, van der Heide A, Rasker JJ, Bijlsma JW. Are tender point scores assessed by manual palpation in fibromyalgia reliable? An investigation into the variance of tender point scores. Scand J Rheumatol 1995;24:243–7.
   Google Scholar
• Fischer AA. Pressure algometry over normal muscles. Standard values, validity and reproducibility of pressure threshold. Pain 1987;30:115–26.
   Google Scholar
• Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 1997; 56:268–71.
   PubMed Web of Science ®Google Scholar
• Hodgues WF, Spielberger CD. An indicant of trait or state anxiety? J Consult Clin Psychol 1969;33:430–4.
   PubMed Web of Science ®Google Scholar
• Zerssen D, Koller DM, Rey ER. [A scale for the objective evaluation of the state of subjective well-being as a method for longitudinal studies]. Arzneimittelforschung 1970;20:915–8.
   Google Scholar
• Flor H, Rudy TE, Birbaumer N, Streit B, Schugens MM. [Applicability of the West Haven-Yale Multidimensional Pain Inventory in the German-speaking area]. Der Schmerz 1990;4:82–7.
   Google Scholar
• Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985;23:345–56.
   Google Scholar
• Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheu-matol 1991;18:728–33.
   Google Scholar
• Offenbacher M, Waltz M, Schops P. Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G). J Rheumatol 2000;27:1984–8.
   Google Scholar
• Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30: 473–83.
   Google Scholar
• National Institute of Mental Health. CGI: Clinical Global Impressions. In: Guy W, Bonato RR, eds. Manual for the ECDEU Assessment Battery.2. Rev ed. Chevy Chase, Md: National Institute of Mental Health; 1970. p. 12–1–12–6.
   Google Scholar
• Wolf H. Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists. Scand J Rheumatol 2000;29 Suppl. 113:37–45.
   Google Scholar
• Barkhuizen A. Rational and targeted pharmacologic treat-ment of fibromyalgia. Rheum Dis Clin North Am 2002;28:261–90.
   PubMed Web of Science ®Google Scholar
• Bennett RM. The rational management of fibromyalgia patients. Rheum Dis Clin North Am 2002;28:181–99.
   PubMed Web of Science ®Google Scholar